期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (4)
Background and ObjectiveTherapeutic drug monitoring (TDM) is an effective tool for the management of patients who are administered linezolid. The use ......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (5)
Quercetin, a naturally occurring flavonoid, has been credited with a wide spectrum of therapeutic properties. However, the oral use of quercetin is li......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (4)
Background and ObjectivesA wide variety of products containing cannabidiol (CBD) are available on the commercial market. One of the most common produc......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (1)
Background and Objectives The Extended Clearance Classification System (ECCS) was established to facilitate the timely anticipation of clearance rate ......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (3)
Background and ObjectivesThe role of therapeutic drug monitoring for ustekinumab in the treatment of Crohn's disease has not been defined. This study ......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (5)
Background and ObjectiveMHV370, a dual antagonist of human Toll-like receptors (TLR) 7 and 8, suppresses cytokines and interferon-stimulated genes in ......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (2)
Background and Objective Little is known about the metabolomic profile of quercetin and its biological effects. This study aimed to determine the biol......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (2)
Background and ObjectiveUnbound daptomycin concentrations are responsible for pharmacologically beneficial and adverse effects, although most previous......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (6)
Background and Objective HSK21542, a synthetic short-chain polypeptide, is a selective peripheral kappa opioid receptor (KOR) agonist. In this single-......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (4)
BackgroundThe demand for physiologically based pharmacokinetic (PBPK) model is increasing currently. New drug application (NDA) of many compounds is s......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (5)
This review provides an overview on the current applications of dried blood spots (DBS) as matrices for therapeutic drug (TDM) and drug or disease res......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; 48 (5)
Messenger RNA (mRNA) has emerged as a new therapeutic agent for the prevention and treatment of a wide range of diseases. The recent achievement of th......
期刊： EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023; ()
Background and ObjectiveAttention deficit hyperactivity disorder is one of the most common neuropsychiatric conditions in children, and methylphenidat......
